Patents by Inventor Pui Shi PANG

Pui Shi PANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250043266
    Abstract: Compositions and methods for the preparation of high purity arginase and high efficiency preparation of monosubstituted polyethylene glycol conjugation of arginase are provided, as are methods for using arginase in combination with asparaginase to inhibit cancer cells. High purity arginase is provided by applying an initial high temperature precipitation step, followed by ion exchange to provide arginase at a purity of 90% or greater. Conjugation with either linear or branched polyethylene glycol is performed using a maleimide-derivatized polyethylene glycol at low molar excess relative to arginase and at reduced temperature. Such polyethylene glycol-derivatized arginase is useful in combination with asparaginase in inhibiting the growth of cancer cells, particularly cells that have low endogenous asparaginase expression.
    Type: Application
    Filed: January 18, 2024
    Publication date: February 6, 2025
    Inventors: Johnson Yiu-Nam LAU, Yun Chung LEUNG, Kuo-Ming YU, Yuk-Keung YEUNG, Pui Shi PANG, Qui-Lim CHOO
  • Patent number: 11898180
    Abstract: Compositions and methods for the preparation of high purity arginase and high efficiency preparation of monosubstituted polyethylene glycol conjugation of arginase are provided, as are methods for using arginase in combination with asparaginase to inhibit cancer cells. High purity arginase is provided by applying an initial high temperature precipitation step, followed by ion exchange to provide arginase at a purity of 90% or greater. Conjugation with either linear or branched polyethylene glycol is performed using a maleimide-derivatized polyethylene glycol at low molar excess relative to arginase and at reduced temperature. Such polyethylene glycol-derivatized arginase is useful in combination with asparaginase in inhibiting the growth of cancer cells, particularly cells that have low endogenous asparaginase expression.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: February 13, 2024
    Assignee: Avalon Polytom (HK) Limited
    Inventors: Johnson Yiu-Nam Lau, Yun Chung Leung, Kuo-Ming Yu, Yuk-Keung Yeung, Pui Shi Pang, Qui-Lim Choo
  • Publication number: 20210189370
    Abstract: Compositions and methods for the preparation of high purity arginase and high efficiency preparation of monosubstituted polyethylene glycol conjugation of arginase are provided, as are methods for using arginase in combination with asparaginase to inhibit cancer cells. High purity arginase is provided by applying an initial high temperature precipitation step, followed by ion exchange to provide arginase at a purity of 90% or greater. Conjugation with either linear or branched polyethylene glycol is performed using a maleimide-derivatized polyethylene glycol at low molar excess relative to arginase and at reduced temperature. Such polyethylene glycol-derivatized arginase is useful in combination with asparaginase in inhibiting the growth of cancer cells, particularly cells that have low endogenous asparaginase expression.
    Type: Application
    Filed: August 16, 2018
    Publication date: June 24, 2021
    Inventors: Johnson Yiu-Nam LAU, Yun Chung LEUNG, Wai Hung LO, Kuo-Ming YU, Yuk-Keung YEUNG, Pui Shi PANG, Qui-Lim CHOO